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Abstract
Transforming growth factor b (TGF-b) signaling acts through Smad proteins to play fundamental roles in cell proliferation,
differentiation, apoptosis, and metabolism. The Receptor associated Smads (R-Smads) interact with DNA and other nuclear
proteins to regulate target gene transcription. Here, we demonstrate that the Caenorhabditis elegans R-Smad DAF-8
partners with the nuclear hormone receptor NHR-69, a C. elegans ortholog of mammalian hepatocyte nuclear factor 4a
HNF4a), to repress the exp-2 potassium channel gene and increase insulin secretion. We find that NHR-69 associates with
DAF-8 both in vivo and in vitro. Functionally, daf-8 nhr-69 double mutants show defects in neuropeptide secretion and
phenotypes consistent with reduced insulin signaling such as increased expression of the sod-3 and gst-10 genes and a
longer life span. Expression of the exp-2 gene, encoding a voltage-gated potassium channel, is synergistically increased in
daf-8 nhr-69 mutants compared to single mutants and wild-type worms. In turn, exp-2 acts selectively in the ASI neurons to
repress the secretion of the insulin-like peptide DAF-28. Importantly, exp-2 mutation shortens the long life span of daf-8 nhr-
69 double mutants, demonstrating that exp-2 is required downstream of DAF-8 and NHR-69. Finally, animals over-
expressing NHR-69 specifically in DAF-28–secreting ASI neurons exhibit a lethargic, hypoglycemic phenotype that is rescued
by exogenous glucose. We propose a model whereby DAF-8/R-Smad and NHR-69 negatively regulate the transcription of
exp-2 to promote neuronal DAF-28 secretion, thus demonstrating a physiological crosstalk between TGF-b and HNF4a-like
signaling in C. elegans. NHR-69 and DAF-8 dependent regulation of exp-2 and DAF-28 also provides a novel molecular
mechanism that contributes to the previously recognized link between insulin and TGF-b signaling in C. elegans.
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Introduction
Transforming growth factor b (TGF-b) signaling plays funda-
mental roles in cell proliferation, differentiation and apoptosis [1].
TGF-b binding induces the formation of a heterotetrameric type I
and type II transmembrane receptor complex, and the type I
receptor then phosphorylates the C-terminal Ser-X-Ser motif of
receptor-associated Smad (R-Smad) transcription factors [2].
Phosphorylated R-Smads form homodimers and heterotrimers
with a Co-Smad and translocate to the nucleus where they
regulate the transcription of target genes [1].
TGF-b signaling is evolutionarily conserved; for example, in the
lower metazoan Caenorhabditis elegans, two partially overlapping TGF-
b signaling pathways have been described. One controls body size
and male reproductive development whereas the other controls the
formation of a specialized larval stage, the dauer [3–5]. The dauer
larva is a developmentally arrested, long-lived and stress resistant
diapause stage, formation of which is induced by overcrowding,
starvation, and high temperatures [5]. Screening for mutations that
result either in constitutive (Daf-c) or defective (Daf-d) dauer
development [5] revealed multiple signaling circuits that control
the dauer developmental switch, including a classical TGF-b
signaling pathway. The TGF-b ligand DAF-7 promotes larval
growth and inhibits dauer arrest; accordingly, transcription of daf-7,
which is expressed in the amphid single ciliated neuron I (ASI)
chemosensory neurons, is repressed by the dauer-inducing phero-
mone[6].Downstreamofdaf-7,daf-1and daf-4encode the nematode
type I and type II TGF-b receptor kinases, respectively, and both
genes are required for non-dauer larval development. DAF-1 and
DAF-4 phosphorylate DAF-8, an R-Smad that antagonizes the Co-
Smad DAF-3 to promote larval growth [7]. In line with these roles,
daf-1, daf-4, daf-7,a n ddaf-8 mutants all exhibit Daf-c phenotypes. In
an interesting divergence from mammalian TGF-b signaling, the C.
elegansCo-SmadDAF-3repressesthetranscriptionoftheantagonistic
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thus creating a positive feedback loop [7].
Dauer formation is also influenced by other sensing and
signaling pathways, such as cyclic guanosine monophosphate
(cGMP) signaling, steroid receptor action and insulin/insulin-like
growth factor 1 (IGF-1) signaling (IIS) [5]. Interestingly, several
recent reports indicate that IIS and TGF-b signaling interact in C.
elegans. In the regulation of fasting/re-feeding induced quiescence,
cGMP, insulin/IGF-1, and TGF-b signaling act as parallel
activation signals for the protein kinase G (PKG) EGL-4 [8]. All
three pathways also affect insulin gene expression, and the gene
expression profiles of TGF-b and IIS pathway mutants exhibit a
rather broad overlap [9–11]. Intriguingly, daf-7 mutants exhibit
increased nuclear localization of the transcription factor DAF-16
[12], a key target of IIS that is also nuclear in worms carrying
mutations in the insulin receptor gene daf-2. Moreover, the
phosphatase PDP-1, which affects TGF-b signaling downstream
of daf-7, and likely at the level of daf-8 and daf-14, also promotes
DAF-16 nuclear localization and insulin gene expression [13].
Thus, PDP-1 and TGF-b signaling may directly promote the
expression of insulin peptides, providing one possible mechanistic
link between TGF-b signaling and IIS. Accordingly, both the Daf-c
and the longevity phenotypes of TGF-b signaling mutants are
suppressed at least partially in a daf-16 mutant [14][9]. These
studies support the notion that TGF-b signaling may in part act
upstream of IIS to regulate dauer formation and longevity.
However, a simple linear relationship between TGF-b and IIS is
unlikely even in the regulation of life span, because the longevity of
TGF-b pathway mutants is very modest compared to IIS pathway
mutants [9]. In any case, the mechanisms that couple IIS and TGF-
b signaling remain poorly defined, and an apparent lack of
recognizable Smad-binding sites amongst the genes co-regulated in
IIS and TGF-b pathway mutants [9] suggests that these signaling
pathways integrate upstream of transcriptional regulation.
Another mechanism that acts downstream of TGF-b signaling
in the dauer formation cascade centers on the Nuclear Hormone
Receptor (NHR) DAF-12 [15]. DAF-12 is one of 284 C. elegans
NHRs that are involved in a variety of processes, including
embryonic development, dauer formation, regulation of life span,
molting, lipid metabolism, xenobiotic metabolism and excretory
duct organogenesis [16][17]. Of the 284 NHRs, most are related
to a Hepatocyte Nuclear Factor 4 alpha (HNF4a) related ancestor.
Most of these remain poorly characterized, although several
HNF4a orthologs regulate lipid metabolism and/or life span [18–
22]. To date however, DAF-12 remains the only NHR with a
defined role in the regulation of dauer formation.
To better define the regulatory network and the transcriptional
complexes associated with C. elegans DAF-8/R-Smad, we set out to
identifyitsphysicalinteractionpartners.Wedescribeanovelphysical
and functional interaction between DAF-8 and NHR-69 that affects
dauer formation, longevity, and the expression of the potassium
channel gene exp-2, which in turn affects the secretion of the insulin-
like peptide DAF-28. Our data indicate that TGF-b signaling and
HNF4a-like signaling exhibit regulatory crosstalk to influence the
secretion of an insulin-like peptide in C. elegans,p r o v i d i n gan o v e l
mechanistic link between TGF-b signaling and IIS.
Results
NHR-69 and DAF-8 physically interact in vitro and in vivo
To identify proteins that bind DAF-8, we used anti-FLAG
immunoprecipitation to purify DAF-8 and associated peptides from
a worm strain stably expressing a DAF-8::FLAG transgene [7].
Peptide identities were determined by mass spectrometry and we
identified several peptides representing NHR-69 (data not shown).
NHR-69 is one of the two closest C. elegans orthologs of human
HNF4a with 39% amino acid identity and 60% similarity (as
determined by reciprocal Blast analysis; see also [23]). To validate
the interaction between these two transcription factors we generated
anti-DAF-8antibodies(FigureS1) and transgenicanimalsexpressing
a translational NHR-69::GFP fusion protein (nhr-69p::nhr-69::gfp;s e e
Materials and Methods). Co-immunoprecipitation (Co-IP) showed
that NHR-69::GFP associates with DAF-8 in vivo (Figure 1A). We
also performed in vitro binding assays using GST-fusions and in vitro
transcribed/translated proteins to test for direct interaction between
NHR-69 andthe functionallydistinctSMAD proteins DAF-8,DAF-
14, and DAF-3. We found that GST::NHR-69, but not GST alone,
associatedspecificallywithDAF-8,butnotwithDAF-14/R-Smador
DAF-3/Co-Smad (Figure 1B). Together, these data suggest that
NHR-69 and DAF-8 specifically interact in vitro and in vivo.
As DAF-8 and NHR-69 interact physically, we would expect
their in vivo expression patterns to at least partially overlap. Our
previous work showed that DAF-8 is expressed in numerous
tissues, including the ASI neurons and the intestine [7]. A NHR-
69::GFP fusion protein driven by the nhr-69 promoter was
detected in the nucleus of the E8 intestinal precursor cells in
developing embryos (Figure 1D, 1F), and strong intestinal
expression persisted throughout larval development until adult-
hood (Figure 1L). In adults, we also detected expression in the ASI
neurons (Figure 1H, Figure S2), in the hypodermis, and in tail
neurons (Figure 1J, 1L and 1N). In all of these tissues, NHR-
69::GFP was localized exclusively to the nucleus, as expected for a
transcription factor. Taken together with our previous findings,
NHR-69 and DAF-8 [7] expression overlaps in the ASI neurons
and in the intestine, suggesting that these two factors may interact
functionally in these two tissues.
nhr-69 mutation enhances dauer formation and delays
dauer recovery of TGF-b Daf-c mutants
Because DAF-8 and NHR-69 interact physically, we next asked
whether NHR-69 affects DAF-8 function. As nhr-69 RNAi does
Author Summary
All animals must ensure metabolic homeostasis; if they fail
to do so, diseases such as obesity and diabetes can
develop. To maintain glucose balance, insulin is secreted
upon glucose intake in a highly regulated and coordinated
process. Previous studies suggested that the transforming
growth factor beta (TGF-b) signaling pathway regulates
insulin secretion in mammals. In the genetically tractable
roundworm Caenorhabditis elegans, TGF-b and insulin
signaling modulate larval development and aging, al-
though the molecular link between insulin and TGF-b
signaling remains poorly understood. In this study, we
show that the TGF-b signaling component DAF-8 partners
with NHR-69, a nuclear hormone receptor, to control the
expression of the potassium channel exp-2, which in turn
modulates the secretion of an insulin-like peptide. A loss-
of-function exp-2 mutant exhibits increased insulin secre-
tion and a shortened life span, whereas a gain-of-function
mutant exhibits decreased insulin secretion. We also show
that tissue-specific expression of nhr-69 in a pair of
neurons that secrete neuropeptides causes reduced
glucose content, increased insulin-like peptide levels and
a lethargic phenotype. Because insulin and TGF-b signaling
are linked to numerous diseases, our data may provide
novel insights into the mechanisms contributing to
pathophysiological changes.
DAF-8 and NHR-69 Modulate Insulin Signaling
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utilized a sensitized genetic background to test whether nhr-69
contributes to dauer formation. This worm strain, eri-1(mg366); sdf-
9(m708), is hypersensitive to RNAi due to the eri-1 mutation [24],
and sensitized to dauer formation due a mutation in the tyrosine
phosphatase gene sdf-9, which acts parallel to IIS in C. elegans [25].
In this background, nhr-69 RNAi significantly enhanced dauer
formation (Figure S3).
To corroborate the RNAi data we obtained a strain carrying a
deletion in the nhr-69 gene, nhr-69(ok1926) (see Materials and
Methods). The deletion spans the 59 end of the gene and likely
represents a null mutation. In agreement with the RNAi data, the
nhr-69(ok1926) mutation enhanced the dauer formation of
temperature-sensitive daf-7(e1372), daf-1(m40), daf-8(m85), and
daf-14(m77) mutants at the semi-restrictive temperature (22.5uC
Table 1; note that even null mutants in the TGF-b pathway like
daf-8 are temperature-sensitive because dauer formation is
temperature-dependent [26]).
TGF-b pathway mutants that constitutively arrest as dauer
larvae at restrictive temperatures (25uC) also exhibit a tempera-
ture-dependent dauer exit phenotype. Thus, we tested whether the
nhr-69(ok1926) mutation compounded the dauer exit phenotype of
TGF-b Daf-c mutants. As expected, TGF-b mutant dauer larvae
rapidly recovered from the dauer state, within 24–48 hours after
Figure 1. Interaction of NHR-69 with DAF-8 and expression pattern of nhr-69p::nhr-69::gfp. (A) In vivo co-immunoprecipitation was
performed with anti-DAF-8 antibody from wild-type worms and nhr-69p::nhr-69::gfp expressing animals, followed by immunoblot with anti-GFP
antibody to detect NHR-69::GFP. (B) In vitro GST pull-down assay between NHR-69 and SMAD proteins (DAF-8, DAF-14, or DAF-3). C–N show DIC and
fluorescence images of developing embryos (C–F) and of adults (G–N) expressing nhr-69p::nhr-69::gfp. (C and D) Expression at the E16 stage of
intestinal precursor cells in embryos. (E and F) Expression at the comma stage. (G and H) Expression in ASI neurons (arrows). (I and J) Hypodermal
expression. (K and L) Intestinal expression. (M and N) Expression in tail neurons. IntP; Intestinal precursor cells, HypN; Hypodermal nucleus, IntN;
Intestinal nucleus, TN; Tail neurons.
doi:10.1371/journal.pgen.1002519.g001
Table 1. Loss of nhr-69 enhances the dauer phenotype of TGF-b signaling mutants.
Strain % dauer formation (N)
Single mutants P value*
Double mutant with nhr-
69(ok1926) P value**
Wild type
c 0 (128) N/A N/A
nhr-69(ok1926)
c 0 (104) N/A N/A
daf-7(e1372)
a 7.662.3 (99) ,0.001 29.563.8 (122) ,0.001
daf-1(m40)
b 60.868.7 (127) ,0.001 83.965.2 (104) 0.012
daf-8(m85)
b 62.361.7 (136) ,0.001 89.662.8 (132) 0.017
daf-14(m77)
b 78.664.5 (118) ,0.001 89.865.9 (94) 0.032
Numbers represent percent dauer formation (average 6 S.E.M.). N=population size. Three young adults of each genotype were placed on NG agar plates seeded with
OP50, then removed after they laid 40–50 eggs. Dauer formation in the F1 generation was scored visually at:
a20uC,
b22.5uC, or,
c25.5uC.
Progeny reaching the L4 stage after 3–4 days (depending on the temperature) were counted and removed. Remaining progeny were scored as dauer larvae.
*Compared to wild type.
**Compared to single mutant.
doi:10.1371/journal.pgen.1002519.t001
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Table 2). In contrast, the nhr-69(ok1926) mutation suppressed the
dauer exit capacity of daf-7(e1372), daf-1(m40), daf-8(m85) and daf-
14(m77) mutants (Table 2). Hence, loss of nhr-69 function not only
enhances dauer formation, but also delays the dauer exit of TGF-b
Daf-c mutants.
Insulin signaling, but not TGF-b signaling, regulates NHR-
69 expression
Because of the enhanced dauer formation phenotype conveyed
by nhr-69 depletion or mutation, and because TGF-b signaling and
insulin signaling both regulate dauer entry and exit [27], we next
asked whether these pathways regulate nhr-69 expression. We used
real-time quantitative PCR (qPCR) to quantify nhr-69 mRNA levels
in the TGF-b pathway mutants daf-7(e1372), daf-1(m40), daf-8(m85)
and daf-14(m77), and in the insulin signaling mutants daf-2(e1370),
daf-16(mgDf47), and daf-2(e1370); daf-16(mgDf47). daf-2 encodes the
C. elegans insulin/IGF-1 receptor and daf-16 a downstream
transcription factor of the Forkhead Box O family [28][29]. The
mRNA levels of nhr-69 were similar in wild-type, daf-1(m40), daf-
7(e1372), daf-8(m85), and daf-14(m77) worms (p.0.05), but were
downregulated in daf-2(e1370) and upregulated in daf-2(e1370); daf-
16(mgDf47) and daf-16(mgDf47) mutants (Figure 2A), suggesting that
DAF-2 regulates nhr-69 in DAF-16–dependent fashion.
Given this regulation and given that NHR-69::GFP is expressed
in multiple tissues, we next addressed whether insulin or TGF-b
signaling affect nhr-69 expression in any particular tissue. To this
end, we generated strains that express the NHR-69::GFP fusion
protein in the daf-2(e1370) and daf-7(e1372) mutant backgrounds.
We observed normal NHR-69::GFP expression in the ASI
neurons of daf-7(e1372) mutants (9663% of L2 larvae showed
GFP fluorescence in both neurons), but NHR-69::GFP was barely
detectable in the ASI neurons of daf-2(e1370) mutants (0.360.04%
of L2 larvae showed GFP fluorescence in both neurons, p,0.001;
Figure 2B c and d). Together, these data suggest that insulin
Table 2. Effect of the nhr-69 mutation on dauer recovery of
TGF-b mutants.
% recovered from dauer (N)
Genotype 24 hrs 48 hrs
daf-7(e1372) 82.764.6 (98) 97.262.1 (110)
daf-1(m40) 80.265.8 (84) 98.761.6 (107)
daf-8(m85) 85.966.3 (94) 97.260.9 (93)
daf-14(m77) 92.463.2 (105) 98.960.4 (99)
daf-7(e1372); nhr-69(ok1926)
a 22.666.2 (95) 53.063.1 (122)
daf-1(m40); nhr-69(ok1926)
b 43.664.5 (103) 78.962.8 (102)
daf-8(m85) nhr-69(ok1926)
c 34.564.8 (100) 67.962.5 (94)
daf-14(m77); nhr-69(ok1926)
d 57.863.9 (102) 82.567.1 (89)
daf-8(m85) nhr-69(ok1926);
mIs39
e
92.961.3 (97) 97.961.2 (103)
Numbers are percent dauer recovery (average 6 S.E.M.). (N), population size.
Three young adults for each genotype were placed on NG agar plates seeded
with OP50, then removed after they laid 40–50 eggs. Dauer larvae were induced
by the restrictive temperature (25.5uC), and plates were transferred to
permissive temperature (15uC) after 72 hrs. The number of L4s and adults
recovered from dauer was scored visually at 24 hrs or 48 hrs after temperature
shift. mIs39[nhr-69p::nhr-69::gfp, rol-6(su1006)].
aRecovery at 24 hrs. Compared to daf-7(e1372):p ,0.001.
bRecovery at 24 hrs. Compared to daf-1(m40):p ,0.001.
cRecovery at 24 hrs. Compared to daf-8(m85):p ,0.001.
dRecovery at 24 hrs. Compared to daf-14(m77):p ,0.001.
eRecovery at 24 hrs. Compared to daf-8(m85)nhr-69(ok1926):p ,0.001.
doi:10.1371/journal.pgen.1002519.t002
Figure 2. Insulin signaling positively regulates nhr-69 expres-
sion. (A) The bars represent relative levels of nhr-69 mRNA as
determined by qPCR on RNA isolated from daf-2(e1370), daf-2(e1370);
daf-16(mgDf47), daf-16(mgDf47), daf-1(m40), daf-7(e1372), daf-8(m85) and
daf-14(m77) mutants (relative to mRNA levels in wild-type worms); mRNA
levels were normalized to act-2. Error bars indicate standard errors of the
mean (SEM) from four biological replicates. (B) Micrographs show DIC
and fluorescence images of NHR-69::GFP in daf-7(e1372) (a and b) and
daf-2(e1370) (c and d) mutants. Arrows indicate the ASI neurons. All
fluorescence images were taken with identical exposure times. (C) Bar
graphs indicate the percentage of animals expressing NHR-69::GFP in ASI
neurons in daf-7(e1372) (black bar, N=78) and in daf-2(e1370) mutant
(white bar, N=83) shown in (B). Error bars indicate SEM.
doi:10.1371/journal.pgen.1002519.g002
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ASI neurons.
Insulin signaling is impaired in a daf-8 nhr-69 double
mutant
The daf-8(m85) nhr-69(ok1926) double mutants exhibited defects
in dauer entry and exit, processes regulated by insulin signaling
[27]; thus, we next asked whether daf-8 and nhr-69 affect insulin
signaling in C. elegans. First, we examined the expression of sod-3
and gst-10, two downstream targets of IIS, which are regulated by
the transcription factors DAF-16 and SKN-1, respectively
[30][31]. SKN-1 is a transcription factor of the bZIP family that
acts downstream of daf-2 in C. elegans. qPCR analysis showed that
both transcripts were upregulated in the daf-8(m85) single mutant;
for sod-3, this is consistent with previous findings that TGF-b
signaling regulates daf-16 target genes [9]. Furthermore, sod-3 and
gst-10 induction was enhanced in the daf-8(m85) nhr-69(ok1926)
double mutant, suggesting that insulin signaling was further
reduced in the double mutant (Figure 3A, 3B).
Because adult life span is extended by reduced insulin signaling
[28], we next tested whether nhr-69 and daf-8 affect longevity.
Figure 3C shows that nhr-69(ok1926) single mutants exhibited a
Figure 3. Reduced insulin signaling and neuropeptide secretion in daf-8 nhr-69 mutants. (A and B) Bar graphs show the relative mRNA
levels of sod-3 and gst-10 in daf-8(m85), nhr-69(ok1926) and daf-8(m85) nhr-69(ok1926) mutants relative to wild-type worms, as determined by qPCR
(normalized to act-2). Age synchronized day-1 adults were used for total RNA extraction. Error bars indicate SEM from three biological replicates. (C)
The plots show population survival of wild-type (grey circles), daf-8(m85) (black circles), nhr-69(ok1926) (purple triangles), daf-8(m85) nhr-69(ok1926)
(blue squares), and mIs39[nhr-69p::nhr-69::gfp] (red inverted triangles) worms at 25.5uC. (D) DIC and fluorescence micrographs show coelomocyte
accumulation (CC, dotted circles) of ANF::GFP (expressed from the oxIs206[aex-3p::ANF::gfp] transgene; b and d) or ssGFP (expressed from the
arIs37[myo-3P::ssGFP] transgene; f and h), respectively, in wild-type worms and in daf-8(m85) nhr-69(ok1926) mutants, as indicated.
doi:10.1371/journal.pgen.1002519.g003
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span 17.461.3 days, p=0.027), whereas the daf-8(m85) mutant life
span was similar to that of wild type (mean life span 14.660.8
days, p.0.05; Figure 3C). Notably, the life span of daf-8(m85) nhr-
69(ok1926) double mutants was significantly longer than that of
wild type worms (mean life span 21.561.7 days, p,0.001;
Figure 3C), consistent with reduced insulin signaling. By contrast,
animals over-expressing NHR-69::GFP exhibited a shortened life
span (mean life span 11.860.6 days, p,0.001) (Figure 3C and
Table S1). Together, these data suggest that daf-8 and nhr-69
cooperatively affect insulin signaling in C. elegans.
Defective neuropeptide secretion in daf-8 nhr-69
mutants
Next, we wished to define the mechanism by which nhr-69 and
daf-8 affect insulin signaling. Given that both genes are expressed
in the neuropeptide-secreting ASI neurons, we hypothesized that
they might control the release of neuropeptides such as the insulin-
like peptide DAF-28, which is secreted by the ASI neurons [32].
To examine this possibility, we first attempted to introduce the
DAF-28::GFP transgene into the daf-8(m85) mutant background.
For unknown reasons, these worms exhibited a non-recoverable
Daf-c phenotype, making it impossible to study DAF-28::GFP
secretion in this background (data not shown). As an alternative
approach, we used worms expressing an aex-3 promoter-driven
ANF::GFP (human Atrial Natriuretic Factor-GFP fusion protein),
which can be used as a surrogate to study neuropeptide secretion
in C. elegans [33]. aex-3p::ANF::GFP is expressed in a pan-neuronal
fashion, secreted into the inter-organ space (pseudocoelom), and
then endocytosed by the coelomocytes, scavenger-like cells that
endocytose secreted material [33]. The accumulation of
ANF::GFP in coelomocytes was similar in wild-type worms and
daf-8(m85) and nhr-69(ok1926) single mutants, but daf-8(m85) nhr-
69(ok1926) double mutants accumulated less ANF::GFP (Figure 3D
d, Figure S4A). The overall neuronal ANF::GFP gene expression
was comparable in all worm strains (Figure S4C).
The differential ANF::GFP accumulation in coelomocytes could
result either from differences in secretion or endocytosis. Thus, we
tested whether the daf-8(m85) nhr-69(ok1926) mutants are generally
defective for endocytosis. Specifically, we examined a signal
sequence GFP (ssGFP) driven by the myo-3 promoter, which is
expressed in muscle cells, secreted into the pseudocoelom and
endocytosed by coelomocytes [34]. The accumulation of ssGFP in
coelomocytes was similar in wild-type worms and in daf-8(m85)
nhr-69(ok1926) double mutants (Figure 3D f and h, Figure S4B),
suggesting that the daf-8(m85) nhr-69(ok1926) mutants are defective
specifically for neuropeptide secretion and not for endocytosis.
NHR-69 directly targets the potassium channel gene exp-
2
Although our data suggest that NHR-69 and DAF-8 control
neuropeptide secretion, the target genes that might underlie this
process remained unknown. Intriguingly, a yeast-one-hybrid
(Y1H) study found that NHR-69 binds the promoter of exp-2,
which encodes a member of the voltage-gated transmembrane
potassium channel (Kv) family [35][36]. Using qPCR, we found
that exp-2 expression was slightly upregulated in the daf-8(m85) and
nhr-69(ok1926) single mutants and synergistically upregulated in
the daf-8(m85) nhr-69(ok1926) double mutant (Figure 4A).
The Y1H data suggested that NHR-69 can directly bind the
exp-2 promoter. Given the similarity of NHR-69 to mammalian
HNF4a, we examined the 2.5 kb region 59 of the exp-2 start codon
for HNF4a-like consensus binding sites [37] and identified four
putative elements (Figure 4B). To test whether NHR-69 directly
binds any of these sites, we performed chromatin immunoprecip-
itation (ChIP) on mixed-stage nhr-69p::nhr-69::gfp animals using an
Figure 4. NHR-69 directly regulates exp-2 transcription. (A) The
bar graphs represent the relative levels of exp-2 mRNA in daf-89(m85),
nhr-69(ok1926), and daf-8(m85) nhr-69(ok1926) mutants relative to wild
type as determined by qPCR (normalized to act-2). Error bars indicate
SEM from three biological replicates. Age synchronized day-1 adults
were used for total RNA extraction. (B) HNF4a binding consensus
sequence and putative NHR-69/HNF4a-like binding sites in the exp-2
promoter region. The positions of possible binding sites 59 of the ATG
of exp-2 are BD1 (22342 bp), BD2 (21832 bp), BD3 (2118 bp) and BD4
(286 bp), respectively. RC, reverse complement. (C) ChIP-qPCR with
anti-GFP antibody reveals that NHR-69 is directly associated with at
least two sites in the 59 regulatory region of exp-2. The arrowheads
indicate the putative HNF4a binding sites shown in (B). Anti-GFP
antibody precipitated sequences from BD1 and BD3 and/or BD4. In a
daf-8 background, binding of NHR-69::GFP was reduced 27% for BD1
and 71% for BD3/BD4. Error bars indicate SEM from three biological
replicates.
doi:10.1371/journal.pgen.1002519.g004
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at least two of these sites (Figure 4C). Intriguingly, NHR-69
binding was reduced, albeit not entirely lost, in daf-8(m85)
mutants, suggesting that DAF-8 is required for optimal NHR-69
binding to the exp-2 promoter (Figure 4C).
To confirm that NHR-69 directly regulates the exp-2 promoter
we developed a mammalian reporter assay. We previously showed
that the nuclear localization of DAF-8 requires the TGF-b Type 1
receptor DAF-1 [7], and others have reported that mutating two
C-terminal serines (Ser465 and Ser467) to glutamates results in
phosphomimetic, constitutively active human Smad2 [38].
Generating a phosphomimetic form of DAF-8 (pmDAF-8) by
changing two orthologous C-terminal serines (S543 and S544) to
glutamate followed by immunohistochemistry showed that
pmDAF-8 localizes to the nucleus in transiently transfected
HEK293 cells (Figure 5A; resembling the nuclear localization of
a DAF-8::GFP fusion protein in C. elegans [7]). NHR-69::GFP was
also localized to the nucleus when transiently transfected into
HEK293 cells (Figure 5A). Importantly, NHR-69::GFP repressed
the activity of a construct in which the wild-type exp-2 promoter is
fused to a luciferase reporter (Figure 5B). Moreover, this repression
was enhanced by co-transfection of pmDAF-8 (Figure 5B),
resembling the results obtained in C. elegans.
To test whether any of the NHR-69 binding sites identified in
our ChIP analysis are functionally important, we performed a
mutational analysis of the exp-2 promoter (Figure 4B and
Figure 5C). Using plasmids carrying exp-2 promoter variants with
mutated NHR-69 binding sites (BD1, BD2, BD3 or BD4) resulted
in 46%, 76%, 18%, and 17% respective reductions of promoter
activity upon NHR-69::GFP and pmDAF-8 co-transfection,
whereas the wild-type exp-2 promoter was repressed by approx-
imately 80% (Figure 5D). These data suggest that BD1, BD3, and
BD4 contribute to exp-2 repression by NHR-69 whereas BD2 is
likely dispensable.
EXP-2 functionally contributes to insulin signaling
downstream of NHR-69 and DAF-8
The above data indicate that exp-2 is a direct target of nhr-69 and
daf-8; thus, we next wished to test whether exp-2 was functionally
required downstream of daf-8 and nhr-69. EXP-2 is a potassium
channel that regulates the action potential in pharyngeal muscle
[36]. Worms carrying a heterozygous exp-2 gain-of-function allele
(exp-2(sa26), encoding an EXP-2 protein with a C480Y point
mutation) exhibit defective feeding behavior, hyperactive head
movements, and egg-laying defects, whereas homozygous worms
arrest terminally after hatching [36][39]. Worms carrying null
mutations in exp-2,s u c ha st h eexp-2(sa26ad1426) allele carrying a
T457I mutation, exhibit no defects in defecation or head
movement, but have long-lasting pharyngeal muscle contractions
[36]. Together, these mutants provide an opportunity to address the
functional requirement of exp-2 in insulin signaling.
To study the effect of exp-2 loss, we generated a daf-8(m85) nhr-
69(ok1926) exp-2(sa26ad1426) triple mutant and found that the life-
span extension due to loss of daf-8 and nhr-69 was abolished by
concomitant loss of exp-2 (Figure 6F, Table S1). Taken together,
our results suggest that NHR-69 and DAF-8 cooperate to directly
regulate exp-2, and that exp-2 is a critical downstream target of
these two transcription factors.
EXP-2 regulates insulin signaling through its actions in
the ASI neurons
Because the exp-2 loss-of-function mutation reduces the
longevity of daf-8(m85) nhr-69(ok1926) double mutants, we next
tested whether exp-2 directly affects insulin signaling. First, we
tested whether loss-of-function and gain-of-function exp-2 mutants
[36] affect the accumulation of the agonistic insulin-like peptide
DAF-28 in coelomocytes. Using a translational DAF-28::GFP
reporter [40], we found that gain-of-function exp-2(sa26) mutants
accumulated less DAF-28::GFP in the coelomocytes than wild-
type worms, whereas loss-of-function exp-2(sa26ad1426) mutants
accumulated more (Figure 6A, Figure S5A).
Because NHR-69 and DAF-8 directly regulate exp-2, and
because DAF-28, DAF-8 and NHR-69 are expressed in ASI
neurons (Figure S2) [7][32], we reasoned that EXP-2 should also
modulate DAF-28::GFP secretion by acting in the ASI neurons. In
support of this possibility, exp-2 is strongly expressed in the amphid
neurons, as well as in the pharyngeal muscle [36]. To address a
putative tissue-specific role for EXP-2, we expressed the exp-
2(sa26) mutant gene under the control of the ASI-specific gpa-4
promoter [gpa-4p::exp-2(sa26)] [41] or the pharynx-specific myo-2
Figure 5. NHR-69 and DAF-8 suppress exp-2 promoter activity
in mammalian cells. (A) Plasmids expressing NHR-69::GFP and a
phosphomimetic variant of DAF-8 (pmDAF-8) were transiently trans-
fected into HEK293 cells and visualized by fluorescence imaging; both
proteins show nuclear localization. (B) The bar graphs depict relative
luciferase activity resulting from a transiently transfected exp-2-driven
luciferase reporter in HEK293 cells. NHR-69, but not pmDAF-8 single
transfection represses the exp-2 promoter, and cotransfection of NHR-
69 and pmDAF-8 causes an even stronger repression. (C) Details on the
site-directed mutagenesis of HNF4a-like binding sites in the exp-2
promoter. (D) The graph depicts the consequence of site directed
mutagenesis of HNF4a-like binding sites in the exp-2 promoter on
luciferase activity. ‘‘No effectors’’ indicates transfection of the reporter
alone, whereas ‘‘WT’’ indicates co-transfection of NHR-69 and pmDAF-8
with the wild-type exp-2 promoter (similar to panel B). Mutating BD1,
BD3, or BD4 attenuates the NHR-69 and pmDAF-8-mediated repression
of exp-2 activity. The result is an average from three individual trials.
doi:10.1371/journal.pgen.1002519.g005
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28::gfp animals. We found that, when exp-2(sa26) was expressed
selectively in ASI neurons, it caused DAF-28::GFP accumulation
at a similar level as seen in exp-2(sa26) worms, whereas pharyngeal
expression of exp-2(sa26) resulted in DAF-28::GFP accumulation
comparable to that observed in exp-2(sa26ad1426); daf-28::gfp
animals (Figure 6A, Figure S5A). Importantly, the mRNA level of
daf-28 was comparable in wild-type, exp-2(sa26), exp-
2(sa26ad1426), gpa-4p::exp-2(sa26) and myo-2p::exp-2(sa26) worms,
as determined by qPCR (Figure S5B). Thus, EXP-2 affects DAF-
28 secretion, but not expression, selectively through its function in
the ASI neurons.
If EXP-2 regulated DAF-28 secretion, it would be expected to
affect downstream insulin target genes and phenotypes such as
longevity. Indeed, the mRNA levels of sod-3 and gst-10 were
upregulated in gain-of-function exp-2(sa26) mutants (Figure 6B,
6C), and we also observed increased nuclear localization of DAF-
16::GFP in the exp-2(sa26) background (Figure S6), consistent with
decreased insulin signaling [43]. Moreover, exp-2(sa26ad1426) loss-
of-function mutants exhibited a significantly shortened life span
compared to that of wild-type worms (mean life span: 9.460.6,
p=0.0116; we were unable to assess adult life span of exp-2(sa26)
mutants due to lethality). In contrast, the life span of the exp-
2(sa26ad1426); daf-2(e1370) double mutants was comparable to
that of the daf-2(e1370) mutant itself (Figure 6E, p=0.7606),
suggesting that exp-2 acts upstream of daf-2 to regulate life span,
consistent with its role in DAF-28 secretion.
Because exp-2 acts selectively in ASI neurons to control DAF-28
secretion (Figure 6A), we next addressed whether life span
regulation by exp-2 also originates from the ASI neurons.
Expression of wild-type exp-2 specifically in the ASI neurons
(gpa-4p::exp-2) rescued the short life span phenotype of exp-
2(sa26ad1426) mutant worms (14.3 days, p=0.0139), whereas
pharyngeal-specific expression did not (8.7 days, p=0.8326;
Figure 6G). This suggests that exp-2 plays an important role in
ASI-neurons to regulate adult life span, possibly through its effect
on DAF-28 secretion. Taken together, these data provide evidence
that life span is inversely related to EXP-2 activity.
Overexpression of NHR-69 in the ASI neurons confers a
hypoglycemic phenotype
As NHR-69::GFP is expressed in ASI neurons and DAF-28 is
produced and secreted in these cells [32], we asked whether NHR-
69 activity in the ASI neurons directly affects insulin signaling.
First, we wished to ensure that an nhr-69::gfp translational fusion
was biologically functional; thus, we expressed nhr-69::gfp from its
own promoter (mIs39[nhr-69p::nhr-69::gfp]). Figure 3C shows that
worms expressing this construct in the daf-8(m85) nhr-69(ok1926)
mutant background exhibited a shortened life span compared to
wild-type and a normal dauer recovery phenotype, suggesting that
functional NHR-69 was overexpressed in these worms (Figure 3C
and Table 2). Having assured that nhr-69 rescue can work in
principle, we generated two transgenic lines that expressed NHR-
69::GFP under the control of the ASI-specific gpa-4 promoter (gpa-
4p::nhr-69::gfp) [41]. In these worms, we observed a higher
accumulation of DAF-28::GFP in coelomocytes (compared to
the wild-type background; Figure 7A). Moreover, the ASI specific
expression of nhr-69::gfp resulted in a lethargic phenotype with
slow, sluggish movement (Figure 7B) reminiscent of hypoglycemia
in mammals [44]. Indeed, the endogenous glucose content was
reduced in gpa-4p::nhr-69::gfp expressing animals compared to that
of wild type (Figure 7C). In agreement with lower glucose levels in
gpa-4p::nhr-69::gfp animals, the lethargic phenotype was almost
completely rescued by exogenous glucose, but not by non-
metabolizable 2-deoxyglucose, suggesting that glucose metabolism,
not uptake is impaired in these animals. We conclude that NHR-
69 overexpression in the ASI neurons results in hypoglycemia
manifested as lethargic behavior, and that NHR-69 acts in the ASI
neurons to regulate DAF-28 secretion.
Discussion
The combinatorial interactions of Smad proteins with other
DNA-binding transcription factors provide a critical selectivity
required to regulate specific subsets of target genes. In this regard,
identifying the transcriptional regulators that cooperate with Smad
proteins will help delineate the mechanisms underlying signal
integration. Here, we describe a molecular crosstalk in C. elegans
whereby the R-Smad DAF-8 partners with NHR-69 to regulate
insulin signaling. We find that NHR-69 and DAF-8 regulate the
exp-2 potassium channel gene, which in turn modulates the
secretion of the insulin-like peptide DAF-28. We further
demonstrate that NHR-69 affects DAF-28 secretion and glucose
homeostasis through its actions in the neuropeptide-secreting ASI
neurons that functionally resemble the mammalian pancreas.
These data not only implicate the HNF4a-like NHR-69 in insulin
signaling, but also suggest a novel mechanism for the previously
suggested link between IIS and TGF-b signaling. Intriguingly,
Narasimhan et al. recently showed that the phosphatase PDP-1
modulates IIS by acting at the level of the Smad proteins DAF-8
and DAF-14 [13]. Taken together with our findings, this
strengthens the notion that there is significantly more crosstalk
between IIS and TGF-b signaling than previously appreciated.
DAF-8 and NHR-69 cooperatively regulate insulin
signaling
We set out to find novel transcriptional partners for DAF-8 and
identified NHR-69 as a candidate DAF-8 interacting protein. In
vivo co-immunoprecipitation and in vitro GST pull-down assays
confirmed that NHR-69 and DAF-8 physically associate, whereas
Figure 6. Insulin signaling is impaired in exp-2 mutants. (A) The micrographs show DAF-28::GFP accumulation in coelomocytes (CC) in wild-
type worms, in exp-2 mutants, and in exp-2 transgenic strains. exp-2(sa26ad1426) loss-of-function and exp-2(sa26) gain-of-function mutants show
increased and decreased DAF-28::GFP intensity, respectively, indicating that EXP-2 represses DAF-28 secretion. ASI-neuron specific expression (driven
by the gpa-4 promoter) of the gain-of-function exp-2(sa26) allele in the exp-2(sa26ad1426) background reduces DAF-28::GFP accumulation, resulting
in a level similar to that seen in the global exp-2(sa26) gain-of-function mutant; in contrast, pharyngeal-specific exp-2(sa26) expression (driven by the
myo-2 promoter) does not alter DAF-28::GFP accumulation in the exp-2(sa26ad1426) background. (B and C) The bar graphs depict average sod-3 and
gst-10 mRNA levels in wild-type (white), exp-2(sa26ad1426) (black), and exp-2(sa26) (grey) worms, as determined by qPCR (normalized to act-2). Error
bars indicate SEM from four biological replicates. (D) The graph depicts population survival curves for wild type worms (white) and exp-2(sa26ad1426)
loss-of-function mutants (black; T=25.5uC). (E) The graph shows population survival curves of daf-2(e1370) (black) and daf-2(e1370); exp-
2(sa26ad1426) mutants (white; T=25.5uC). (F) The graph depicts population survival curves of wild-type (black circle), daf-8(m85) nhr-69(ok1926) (blue
circle), exp-2(sa26ad1426) (red square), and daf-8(m85) nhr-69(ok19260; exp-2(sa26ad1426) (green square) worms (T=25.5uC). (G) The graph shows
population survival curves of wild-type (white), exp-2(sa26ad1426) (black), exp-2(sa26ad1426); gpa-4p::exp-2 (red) and exp-2(sa26ad1426); myo-2p::exp-
2 (green) (T=25.5uC). All strains shown in this panel also harbor the pRF4[rol-6(su1006)] transgene.
doi:10.1371/journal.pgen.1002519.g006
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indicating that the interaction is specific for DAF-8. We also
found evidence for a functional interaction between DAF-8 and
NHR-69, demonstrating that nhr-69 is involved in dauer
formation: depletion of nhr-69 by RNAi enhanced dauer formation
in sensitized genetic backgrounds, including sdf-9 and several
TGF-b Daf-c mutants. Furthermore, resumption of normal larval
development of daf-1, daf-7, daf-8 and daf-14 dauer larvae after
temperature downshift was delayed approximately two-fold in the
nhr-69 mutant background. Because daf-2 signaling is required for
temperature-dependent dauer recovery [27], this result suggests
that insulin signaling was impaired in nhr-69 mutants.
In line with this notion, we observed an extended life span and
upregulation of the insulin-regulated genes sod-3 and gst-10 in the
daf-8 nhr-69 double mutant. We note that the observed longevity
likely reflects altered expression of genes other than just sod-3 and
gst-10, akin to the observations made in long-lived daf-2 mutants,
wherein numerous genes are thought to contribute to longevity
[9]. Lastly, we observed a reduced accumulation of ANF::GFP in
the coelomocytes of daf-8 nhr-69 double mutants, indicating that
neuropeptide secretion is impaired in daf-8 nhr-69 double mutants,
representing the likely cause for impaired insulin signaling.
The relationship between TGF-b signaling and IIS may be
conserved in evolution. Members of the TGF-b superfamily affect
the development and physiology of mammalian pancreatic b-cells,
although the results are somewhat conflicting. In one study,
Smad3 repressed the insulin gene promoter and Smad3
knockdown enhanced glucose stimulated insulin secretion (GSIS)
[45], suggesting a repressive role for TGF-b signaling. However, in
isolated rat fetus pancreatic b-cells, TGF-b1 stimulates long-term
(48 hours) insulin secretion [46], perhaps through transcriptional
changes. Similarly, TGF-b1 and Activin A, another TGF-b family
member, stimulate short-term (five minutes) insulin secretion in
mouse insulinoma cells by increasing cytoplasmic Ca
2+ concen-
tration [47][48]. In addition, conditional expression of the
inhibitory Smad7 in b-cells resulted in reduced pancreatic insulin
levels and in hypoinsulinemia. Lastly, expression of the TGF-b
related bone morphogenetic protein 4 (BMP4) and its receptor
BMPR1A regulate glucose metabolic genes to enhance GSIS and
promote insulin signaling [49]. Our results are more consistent
with the latter reports as the daf-8 nhr-69 double mutant exhibited
decreased overall insulin signaling.
NHR-69 and DAF-8 control exp-2 expression to regulate
DAF-28 secretion
Mechanistically, several lines of evidence suggest that NHR-69
and DAF-8 influence DAF-28 secretion by directly regulating the
expression of exp-2, which encodes a voltage-activated (Kv-type)
potassium channel. Using ChIP, we found that NHR-69
associated with at least two elements in the exp-2 promoter region
that resemble consensus HNF4a binding sites; moreover, this
binding was reduced in daf-8 mutants. daf-8 nhr-69 double mutants
synergistically induce exp-2 expression, suggesting that exp-2 is
repressed by these two factors. Interestingly, using expression
profiling, Shaw et al. previously found exp-2 to be induced in
several TGF-b Daf-c mutants, including daf-8 mutants [9],
although they did not report the extent of the upregulation (we
observed a mild induction in daf-8 mutants that was not
statistically significant; see Figure 4A). Lastly, we used a
heterologous cell culture system to confirm that NHR-69 and
DAF-8 collaboratively repress exp-2, with three distinct NHR-69
binding sites being required for full repression.
Together, our results imply that NHR-69 and DAF-8 assemble
a complex on the exp-2 promoter that represses exp-2 transcription.
Due to the divergent nature of the DNA-binding domain of DAF-
8 (only 28% similar to the MH1 domain of human Smad1, and
30% similar to the MH1 domain of Drosophila melanogaster Mad1;
Park & Taubert, unpublished), it is difficult to predict whether
DAF-8 would bind to the consensus Smad-binding-element (SBE)
[50]. Further experiments are required to assess whether DAF-8
directly binds the exp-2 promoter or whether it is tethered to this
region through an interaction with NHR-69.
Our data further indicate that exp-2 is critical for insulin
signaling downstream of DAF-8 and NHR-69 (but upstream of
DAF-2). Firstly, the exp-2(sa26ad1426) mutation, which shortens
the life span of wild-type worms, did not shorten the life span of
daf-2 mutants. Secondly, exp-2(sa26ad1426) and exp-2(sa26)
mutants altered DAF-28 secretion. Thirdly, exp-2(sa26) mutants
exhibited increased nuclear localization of DAF-16/FoxO, a
typical consequence of reduced DAF-2 activity. Lastly, the exp-
2(sa26) mutant showed increased expression of two downstream
DAF-2 target genes. Thus, we find evidence for a novel regulatory
relationship between insulin secretion and TGF-b signaling. As
nhr-69 transcription is itself induced by insulin signaling, a positive
Figure 7. ASI-specific over-expression of NHR-69 confers
hypoglycemia. (A) The bar graphs show the relative DAF-28::GFP
level in coelomocytes (CC) in wild-type and mIs40[gpa-4p::nhr-69::gfp]
day-1 old adult worms. Error bars indicate SEM. N=62 in wild type,
N=77 in mIs40[gpa-4p::nhr-69::gfp] backgrounds (p,0.001). (B) Bars
indicate the percentage of lethargic animals in the presence or absence
of exogenous glucose (2 mM Glc) or 2-dexoyglucose (2 mM 2-DOG).
Synchronous day-1 adults were video recorded for two minutes
individually and worms that stopped and resumed moving more than
four times were judged to be lethargic (N=50). (C) Bars show
endogenous glucose content in wild-type and mIs40[gpa-4p::nhr-
69::gfp] worms. Synchronous day-1 adults were assayed in four
independent biological replicates. Error bars indicate SEM.
doi:10.1371/journal.pgen.1002519.g007
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formation is initiated, but only when environmental stimuli
activate both TGF-b and insulin signaling.
EXP-2 is a member of the six-transmembrane, voltage-activated
potassium channel family, which also controls muscle contraction
in the C. elegans pharynx. EXP-2 produces an outward current at
the plasma membrane, which terminates the action potential by
repolarizing the membrane [36]. As EXP-2 exhibits homology to
multiple mammalian Kv-type channels it is difficult to provide a
direct parallel to the functions of one mammalian channel.
However, several Kv-type channels are known to affect insulin
signaling and/or glucose balance [51]. Most prominently,
pharmacological inhibition or genetic disruption of Kv2.1 causes
increased glucose-stimulated insulin secretion [52][53]. In the
future, it will be interesting to test whether NHR action and TGF-
b signaling coregulate these mammalian channels.
Neuronal NHR-69 overexpression affects glucose
homeostasis and DAF-28 secretion
The expression of nhr-69 overlaps with that of daf-8 in ASI
neurons and in the intestine [7], suggesting that the molecular
crosstalk between DAF-8 and NHR-69 may occur in these two
tissues. Cell ablation analyses demonstrated that the ASI neurons
inhibit dauer formation [54], and are required for the expression of
the TGF-b ligand DAF-7 and of the insulin-like peptide DAF-28,
both of which promote reproductive growth [55][32]. Because of
the latter property, the ASI neurons have been proposed to
functionally resemble the insulin-producing pancreatic b-cells [40].
To test whether NHR-69 was functionally important in the ASI
neurons, we generated a strain that overexpresses nhr-69 specifically
in these neurons. These worms exhibited greater accumulation of
DAF-28::GFP, a lethargic phenotype, and reduced glucose levels,
reminiscent of a hyperinsulinemic/hypoglycemic phenotype [44].
NHR-69 may achieve these effects by regulating other neuropep-
tides in addition to DAF-28; in any case our results suggest that the
regulation of NHR-69 levels and activity in the ASI neurons is
critical to achieve glucose homeostasis in C. elegans. They also
support the notion that ASI neurons exhibit characteristics of
mammalian pancreatic b-cells [40]. We note, however, that NHR-
69 and DAF-28 are also co-expressed in the intestine, a tissue that
plays a key role in metabolic regulation in C. elegans and may also
perform pancreas related functions.
Our overall model (Figure 8) integrates the observations
described above: in favorable conditions, DAF-8 and NHR-69
cooperate to repress exp-2 transcription in the ASI neurons, thus
causing sustained DAF-28 secretion, which in turn activates IIS
and promotes reproductive growth. This mechanism would act in
parallel to the one proposed by Narasimhan et al., whereby DAF-8
promotes IIS and reproductive growth by directly inducing the
transcription of agonistic insulin peptide genes such as ins-4 [13].
In harsh conditions, exp-2 transcription is de-repressed as a
consequence of reduced DAF-8 phosphorylation and lower nhr-69
expression; increased EXP-2 activity would presumably lead to a
rapid reduction in the overall levels of agonistic insulins, thus
providing a rapid signal for dauer formation (Figure 8).
NHR-69 functionally resembles pancreatic HNF4a
The C. elegans genome encodes 284 NHRs, most of which derive
from an HNF4a-like ancestor. The human HNF4A gene encoding
HNF4a is mutated in a subtype of MODY (Maturity Onset
Diabetes of the Young) and HNF4a is a central regulator of
hepatic and pancreatic gene transcription [37]. MODY patients
fail to properly secrete insulin in response to glucose challenge [56]
and b-cell-specific knockout of HNF4a in mice results in reduced
GSIS [57][58]. Intriguingly, akin to our discovery of physical and
functional DAF-8:NHR-69 interaction, HNF4a and Smad3
interact physically and functionally in transfected human cells
[59], although the physiological impact of this interaction remains
unclear. Our study suggests that such HNF4a:Smad complexes
may affect glucose homeostasis by regulating potassium channel
genes in pancreatic b-cells.
The functions of most C. elegans HNF4a-related NHRs remain
unknown and no C. elegans NHR has yet been implicated in
glucose and/or insulin metabolism. We provide several lines of
evidence that NHR-69 performs these particular functions,
somewhat resembling pancreatic HNF4a. Most compellingly, we
observe hypoglycemia in animals that overexpress NHR-69
specifically in ASI neurons [32][40]. However, we note that,
compared to HNF4a, the defects in nhr-69 single mutants (and in
nhr-69 heterozygotes) are relatively mild indicating that possibly
other NHRs such as the closely related NHR-64 act redundantly
or can compensate for the loss of nhr-69. Given the vast number of
HNF4a-related NHRs in C. elegans, other NHRs may also control
dauer formation, especially in a sensitized genetic background. As
many C. elegans NHRs form heterodimers [60], we speculate that
NHR-69 may form heterodimers to implement its regulatory roles.
Human HNF4a targets hundreds of genes in the liver and
pancreas to modulate metabolic processes such as lipid biosyn-
thesis, glucose homeostasis and insulin secretion [37]. However,
the molecular and physiological functions of individual HNF4a
target genes and their combinatorial regulation remains poorly
understood. Identifying the functions and the target genes of C.
elegans HNF4a-like NHRs can provide insights into the mechanism
of related mammalian NHRs. We recently proposed that the
functions collectively executed by mammalian HNF4a might be
distributed amongst individual C. elegans HNF4a orthologs [17].
For example, NHR-31 regulates the expression of a vacuolar
ATPase in the excretory cell in C. elegans [61], possibly hinting at a
similar regulatory role of mammalian HNF4a in kidney
physiology. Our results suggest that NHR-69 may be a partial
functional ortholog of pancreatic HNF4a. Thus, NHR-69 may
provide a useful tool to dissect pancreatic HNF4a function, to
define in vivo regulators of HNF4a and to delimit additional
downstream targets that participate in the regulation of glucose
homeostasis.
Materials and Methods
Nematode strains
C. elegans strains were cultured according to standard techniques
[62] unless otherwise noted. The E. coli strain OP50 was used as a
food source in all assays. Nematode strains and alleles used in this
study are LG I: daf-8(sa343), daf-8(m85), nhr-69(ok1926) daf-
16(mgDf47); LG III: daf-7(e1372), daf-2(e1370);L GI V :daf-1(m40),
eri-1(mg366), daf-14(m77);L GV :exp-2(sa26)/eT1[let-?(n886)], exp-
2(ad26ad1426), sdf-9(m708). mIs1[rol-6(su1006)], mIs39[nhr-69p::nhr-
69::gfp, rol-6(su1006)], mIs40[gpa-4p::nhr-69::gfp, rol-6(su1006)], mIs4[-
rol-6(su1006)], mIs27[daf-8p::daf-8::gfp, rol-6(su1006)], nhr-69(ok1926);-
daf-1(m40), nhr-69(ok1926); daf-7(e1372), daf-8(m85) nhr-69(ok1926),
daf-8(m85) nhr-69(ok1926); mIs39, nhr-69(ok1926);daf-14(m77), daf-
7(e1372); mIs39, daf-2(e1370);mIs39, daf-8(m85) nhr-69(ok1926); oxI-
s206[aex-3p::ANF::GFP], daf-8(m85) nhr-69(ok1926); arIs37[myo-
3p::ssGFP], exp-2(sa26); svIs69[daf-28p::daf-28::gfp], exp-2(sa26ad1426);
svIs69[daf-28p:daf-28::gfp], daf-2(e1370); exp-2(sa26ad1426), daf-8(m85)
nhr-69(ok1926); exp-2(sa26ad1426) exp-2(sa26); zIs356[daf-16p::daf-
16::gfp], mIs40; svIs69.
In the nhr-69(ok1926) mutant, 1329 bp are deleted, including
the 59 upstream regulatory sequences and the first four exons
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predicted to truncate DAF-8 in the conserved MH2 domain. It
is the strongest daf-8 allele, forming virtually 100% dauer larvae at
25.5uC [7].
Transgene construction and transformation
A genomic fragmentcontainingtheentire codingregionofnhr-69
plus 3 kb upstream of the ATG was amplified. The gfp gene was
amplified from pPD95.75 (kindly provided by A. Fire) and used for
PCR fusion (see [63]) to generate nhr-69p::nhr-69::gfp, a translational
fusion of gfp at the end of nhr-69 exon 9. The gpa-4p::nhr-69::gfp
fusion construct was generated by the same method, with a 2.8 kb
59 gpa-4 promoter region [41] being used. The fusions were
introduced by microinjection into the adult germ line (45 ng/ml)
along with the injection marker pRF4 [rol-6 (su1006)] (9 ng/ml).
Life span analysis and measurement of glucose content
Eggs were prepared by alkaline hypochlorite treatment and
synchronized by hatching in M9 buffer. After growth on OP50 at
15uC, animals at mid-L4 stage were transferred to NG agar plates
containing 40 mM of 5-fluoro-29-deoxyuridine (FUdR) to prevent
progeny production [64]. Life span experiments were performed
at 25uC as previously described [65]. We averaged mean life spans
from three independent biological replicates. Representative
survival curves are shown. We used one-way analysis of variance
(ANOVA) for statistical analysis of mean life spans ANOVA [66].
We measured total worm glucose levels with a Glucose Assay
Kit (Biovision K606–100). Worms grown on NG agar plates were
collected and washed five times in M9 buffer. The worm pellet was
resuspended in 500 ml of glucose assay buffer, frozen at 280uC,
thawed on ice, and then sonicated (Branson Sonifier 450) five
times (output level 3, time 10 seconds) to obtain extracts. After
centrifugation at 13,000 rpm at 4uC, the supernatant was used for
the glucose assay according to the manufacturer’s instructions. We
normalized glucose content by protein content in each sample.
Statistics were performed using GraphPad Prism 5.
Lethargy assays
Worms were grown synchronously at 20uC from L1 to L4 stage,
and then transferred to 25uC. Individual day-1 old adults were
Figure 8. Working model for DAF-8 and NHR-69 modulation of insulin secretion in C. elegans. Based on our data, we propose that DAF-2
signaling positively regulates transcription of nhr-69, whereas the TGF-b receptor is known to phosphorylate DAF-8 to activate its function [7]. NHR-
69 and DAF-8 cooperatively repress the transcription of the exp-2 Kv channel gene in ASI neurons, which in turn causes sustained secretion of the
insulin-like peptide DAF-28, hence activating a feed-forward loop on DAF-2 in favorable conditions. TGF-b and Insulin/IGF-1 signaling crosstalk at the
exp-2 promoter through the DAF-8 and NHR-69 transcription factors. Upregulation of exp-2 by the reduction of DAF-8 and NHR-69 activity would
attenuate DAF-28 secretion, providing a fast decision for the dauer formation.
doi:10.1371/journal.pgen.1002519.g008
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they stopped and resumed moving more than four times (N=50).
The plates were tapped manually ten seconds prior to video
recording to stimulate movement. For assaying suppression of
lethargy by glucose, worms were grown as above and transferred
to NG-agar plates supplemented with either 2 mM of D-(+)-
Glucose (Sigma, G8270) or 2 mM of 2-deoxy-D-glucose (Sigma
D8375).
RNAi and dauer formation and recovery assays
Percent dauer formation was scored visually at 2506 magni-
fication for each genotype grown for two days from hatching at
20uC, 22.5uC, and 25.5uC. To assay dauer recovery, the dauer
larvae were induced by growth at 25.5uC for each genotype. 50
dauer larvae were put on NG agar plates seeded with OP50 and
incubated at 15uC. Dauer recovery was scored visually monitoring
pharyngeal pumping and body size 24 and 48 hrs after transfer.
RNAi feeding was performed using clones from the Ahringer
library [67] on 1 mM Isopropyl b-D-1-thiogalactopyranoside
(IPTG) as described [68].
In vitro GST pull down, in vivo co-immunoprecipitation,
and immunoblots
For in vitro GST pull down assays, full-length cDNAs encoding
NHR-69 or Smad proteins were subcloned into pGEX-4T-1 (GE
Healthcare Sciences) and pBluescript SKII vectors, respectively.
The GST pull-down assay and in vivo co-IP were performed as
previously described [7]. Immunoblots were probed with anti-GFP
antibody (1:2,000, Abcam ab6556) or anti-DAF-8 antibody
(1:1,000; a custom rabbit polyclonal anti-DAF-8 antibody raised
against the peptide CQSNRQDDEEPGYYR, generated by
GenScript). Total lysates were obtained by sonication (Branson,
Sonifier 450). The anti-DAF-8 antibody specifically detected
endogenous DAF-8 as well as the exogenous DAF-8::GFP fusion
protein, but did not detect DAF-8 in the daf-8(sa343) mutant, in
which the epitope is deleted (Figure S1).
Chromatin immunoprecipitation (ChIP) and quantitative
PCR
For ChIP, mixed-stage populations were subjected to a 1.5%
formaldehyde solution for 30 minutes at room temperature to
cross-link DNA and proteins [69]. We performed immunoprecip-
itation by incubating the lysate with either anti-GFP antibody
(1:250, Abcam) or IgG at 4uC for 16–18 hours. The precipitates
were washed, the crosslinks reversed, and the DNA eluted. 5 mlo f
each eluate were used for quantitative PCR (qPCR).
For qPCR, 1 mg total RNA from each sample was used for
reverse transcription with Superscript II reverse transcriptase
(Invitrogen) and oligo dT priming. The resulting first-strand
cDNA was analyzed by qPCR on an Applied Biosystems 7500
with BioRad iTaq SYBR green supermix using ROX as a
normalization dye. The primers used for qPCR are listed in Table
S2.
Antibodies, immunohistochemistry, and promoter
analysis in HEK293 cells
The phosphomimetic pmDAF-8 construct was amplified by
PCR with primers dh_295_L and dh_296_R (Table S2). The
resulting cDNA was cloned into the pcDNA3.1 (+) Neo vector
using BamHI and EcoRI sites. The cDNA for nhr-69::gfp was
amplified from mIs39 animals by using dh_312_L and dh_313_R
(Table S2). The resulting PCR product was cloned in the
pcDNA3.1 (+) Hygro vector using NheI and ApaI sites. The
wild-type 2.5 kb exp-2 promoter was PCR amplified using
dh_299_L/dh_300_R (Table S2) and subcloned in pTK-GLuc
vector (New England BioLabs N8084) using KpnI and BamHI
sites to generate pTK-Gluc/exp-2. The mutant exp-2 promoter
constructs were generated using a site directed mutagenesis kit
(Invitrogen) with pTK-Gluc/exp-2 as a template. The constructs
were delivered to HEK293 cells by transient transfection using
Lipofectamine (Invitrogen) according to the manufacturer’s
manual. The luciferase assays were performed using a BioLux
Gaussia Luciferase Flex Assay Kit (New England BioLabs
E3308L), and luminescence was measured in a Tecan M200
plate reader.
For immunofluorescent detection of labeled proteins, cells were
fixed in 4% paraformaldehyde for 10 minutes, washed in PBS
twice for five minutes per wash, permeabilized in 0.1% Triton-X-
100 for 30 minutes, washed in PBS, and blocked in 4% Normal
Goat Serum for 45 minutes, incubated with primary antibodies
overnight in PBS/1% Normal Goat Serum. The following
morning, the samples were washed twice with PBS and incubated
with secondary antibodies for 1 hour, then washed 365 minutes
in PBS. The coverslips were mounted using Vectashield (Vector
Laboratory). The primary antibodies were: anti-DAF-8 (1/500)
custom rabbit polyclonal antibody (Genscript), anti-Vimentin (1/
200 Chicken IgY, Millipore #AB5733). The secondary antibodies
were Alexa 546-coupled anti-rabbit IgG H+L, highly cross-
adsorbed (1/200, Invitrogen/Molecular Probes #A11035), and
donkey anti-chicken Cy5 (1/200, Millipore #AP194S).
Microscopy
We used a Zeiss Axioscope equipped with a QImaging camera
(RETIGA 2000R) for differential interference contrast (DIC) and
fluorescence microscopy. ImageJ software was used to estimate the
intensity of the GFP signal in coelomocytes. For DiI staining,
cultures were synchronized by hatching purified eggs into M9
buffer, grown on NG agar plates until the L2 stage, washed in M9
buffer, and DiI stained, as described [70]. Fluorescent signals
generated by immunostaining were visualized and captured using
an Olympus FLUOVIEW FV10i confocal laser-scanning micro-
scope system. Images from different color channels were colorized
and merged using ImageJ software.
Supporting Information
Figure S1 Anti-DAF-8 antibody specifically detects endogenous
DAF-8. Mixed-stage worms were washed three times with M9
buffer and SDS sample buffer was added to the worm pellet. Total
protein extracts were obtained by boiling. 40 mg of total protein
was loaded into each well. The blot was probed with anti-DAF-8
antibody (1:1,000).
(TIF)
Figure S2 nhr-69p::nhr-69::gfp and daf-8p::daf-8::gfp are expressed
in the ASI neurons. Dorsal view of expression in ASI neuron
(arrow in lower panel). The same animals were stained with DiI for
ciliated neurons in the head (arrows in middle panel).
(TIF)
Figure S3 RNAi against nhr-69 enhances dauer formation. The
bar graphs show the percentage of wild type or eri-1(mg366); sdf-
9(m708) worms that formed dauer larvae when grown on HT115
bacteria harboring control RNAi plasmid (No), or gfp, akt-1,o rnhr-
69 RNAi plasmids. Worms were initially grown on OP50 at 15uC,
transferred to lay eggs on plates with bacteria harboring the
indicated RNAi construct, and then removed. The F1 progeny
were grown to the L4 stage at 15uC; then, three F1 L4 larvae were
DAF-8 and NHR-69 Modulate Insulin Signaling
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adults after they had laid 30–40 eggs. Dauer formation in these F2
worms was then scored visually. akt-1 RNAi was used as the
positive control because we previously found that it promotes
dauer formation in the eri-1; sdf-9 background.
(TIF)
Figure S4 Accumulation of neuropeptide-GFP fusion proteins in
coelomocytes (CC) and quantification of ANF::GFP expression.
(A) Quantification of ANF::GFP in coelomocytes of wild type and
daf-8(m85) nhr-69(ok1926) worms (black, p,0.001) indicates that
the mutant strain is deficient in neuropeptide secretion. The daf-8
(grey) and nhr-69 single mutants (hatched) showed 10.2% and
15.4% reduction in the GFP intensity, respectively. (B) Quanti-
fication of coelomocyte ssGFP in wild type and daf-8(m85) nhr-
69(ok1926) worms (p.0.05) shows that the difference seen in (A) is
not due to a deficiency in coelomocyte uptake. The intensity in
either daf-8 (grey) or nhr-69 (hatched) single mutant was
comparable to that of wild type (p.0.05). (C) qPCR for gfp
mRNA from animals expressing aex-3p::ANF::GFP in wild type and
daf-8 nhr-69, daf-8 and nhr-69 (p.0.05) shows that the expression of
intestinal peptides is similar in all strains. Bars indicate SEM for
four independent experiments.
(TIF)
Figure S5 Coelomocyte DAF-28::GFP accumulation and daf-28
expression inexp-2 mutants.(A) Quantification of coelomocyte DAF-
28::GFP in wild type worms, loss-of-function exp-2(sa26ad1426) and
gain-of-function exp-2(sa26) mutants (p,0.001), and worms express-
ing exp-2(sa26) in ASI-specific (red bar, p.0.05 compared to exp-
2(sa26) mutant) or pharyngeal-specific fashion in the exp-
2(sa26ad1426) mutant background (green bar, p=0.7966 compared
to exp-2(sa26ad1426) mutant). (B) qPCR quantification of daf-28
mRNA levels in wild-type, loss-of-function exp-2(sa26ad1426),a n d
gain-of-function exp-2(sa26) worms (p.0.05). Red and green bars
represent mRNA levels in worms expressing exp-2 in ASI-specific or
pharyngeal-specific fashion, respectively. Error bars indicate SEM.
(TIF)
Figure S6 DAF-16::GFP exhibits nuclear localization in the
gain-of-function exp-2(sa26) mutant.
(TIF)
Table S1 Life span phenotype described in the text.
(DOC)
Table S2 PCR Primers described in the text.
(DOC)
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